Loading chat...
IN SR0071
Resolution
Status
Passed
4/18/2011
Primary Sponsor
Patricia Miller
Click for details
AI Summary
- Urges the Legislative Council to assign the Health Finance Commission to study requiring competitive bidding among generic drug manufacturers supplying products to Medicaid recipients
- Study would examine whether the Family and Social Services Administration should implement a competitive bidding process for generic drugs provided to Medicaid patients
- Generic drugs offer 30% to 80% savings compared to brand name equivalents while meeting the same FDA quality and testing standards
- Currently, Indiana's Medicaid program encourages generic drug use but does not utilize competitive bidding despite significant price variation among generic manufacturers
- Resolution introduced during the First Regular Session of the 117th General Assembly (2011)
Legislative Description
Study of generic drug manufacturers and Medicaid recipient bidding process.
Last Action
Second reading: adopted voice vote
4/18/2011
Full Bill Text
No bill text available